Error in Figure - Report - MDSpire

Error in Figure

  • May 28, 2026

  • 0 min

Share

Correction of Graphical Error in Figure 2

Overview

This report addresses a correction made to the graphical representation in Figure 2 of the original investigation titled 'Hypertrophic Cardiomyopathy and Risk of Out-of-Hospital Cardiac Arrest.' The correction involved the accurate labeling of lines in the graph.

Background

Hypertrophic cardiomyopathy (HCM) is a significant condition associated with an increased risk of out-of-hospital cardiac arrest (OHCA).

Data Highlights

No numerical or trial data is presented in the correction notice.

Key Findings

  • The original investigation reported on HCM and its association with OHCA.
  • Figure 2 contained incorrectly labeled lines that have now been corrected.

Clinical Implications

Healthcare professionals should ensure that they refer to corrected figures in published studies to avoid misinterpretation. Accurate data representation is vital for effective clinical decision-making.

Conclusion

The correction of graphical errors in clinical research is essential for maintaining the accuracy and reliability of published findings.

Related Resources & Content

  1. JAMA Network, JAMA Network Open, 2026 -- Hypertrophic Cardiomyopathy and Risk of Out-of-Hospital Cardiac Arrest
  2. Erratum: 3D Reconstruction from Microscopic Imaging for Computer-Assisted Eye Surgery
  3. Journal of Neuro-Oncology (Springer) — Erratum: Evaluating Phosphoenolpyruvate Carboxykinase 2 as a Prognostic Indicator: Its Expression and Clinical Relevance in Group 3 and Group 4 Medulloblastoma
  4. Acta Neuropathologica — Erratum: The Role of Intraneuronal β‑CTF Fragment Aggregation in Inducing Aβ‑Independent Lysosomal-Autophagic Pathology
  5. Erratum: Comparing the "true" acetabular anteversion angle (AV angle) using 2D CT and 3D modeling techniques
  6. Hypertrophic Cardiomyopathy and Risk of Out-of-Hospital Cardiac Arrest | Congenital Defects | JAMA Network Open | JAMA Network
  7. EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy | European Journal of Heart Failure | Oxford Academic
  8. A Study of Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy - American College of Cardiology

Original Source(s)

Related Content